Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease liver cirrhosis
Phenotype C0019204|hepatocellular carcinoma
Sentences 74
PubMedID- 22666283 Sorafenib prevents escape from host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma.
PubMedID- 23769105 Liver transplantation (lt) is a life-saving treatment for liver cirrhosis patients with hepatocellular carcinoma (hcc).
PubMedID- 22363353 Some individuals with persistent hcv infections develop liver cirrhosis, which can lead to hepatocellular carcinoma in some patients [1][2][3][4].
PubMedID- 25903707 Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.
PubMedID- 24760057 Biochemical nutritional profile of liver cirrhosis patients with hepatocellular carcinoma.
PubMedID- 23146511 Introduction: the coexistence of liver cirrhosis with hepatocellular carcinoma (hcc) and colon cancer (ca), which is a rare clinical condition, was treated in a liver transplant recipient.
PubMedID- 24223741 Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
PubMedID- 22523693 These pleiotropic and highly variable functions go some way towards explaining the miscellany of associations that have been detected for vdr polymorphisms, among others with the occurrence of hepatocellular carcinoma (hcc) in patients with liver cirrhosis, particularly in patients with an alcoholic etiology [30].
PubMedID- 25702281 Serum paraoxonase 1 (pon1) is highly fucosylated in hepatocellular carcinoma (hcc) compared with liver cirrhosis (lc).
PubMedID- 26116049 Risk factors for incisional hernia after hepatic resection for hepatocellular carcinoma in patients with liver cirrhosis.
PubMedID- 25091611 hepatocellular carcinoma (hcc)-closely associated with liver cirrhosis and, in fact, the main cause of death in patients with such disease-is now recognized as one of the most-prevalent and lethal neoplasms worldwide.
PubMedID- 22254115 Chronic ethanol consumption causes changes in the liver, including fatty liver, inflammation and cirrhosis [179], and is an established risk factor for the development of hepatocellular carcinoma in patients with liver cirrhosis [180].
PubMedID- 20087783 Background: the antiangiogenic drug sorafenib has been shown to be an effective treatment for hepatocellular carcinoma (hcc) in patients with liver cirrhosis.
PubMedID- 23918576 Patients were excluded for one of the following: 1) ascites due to liver cirrhosis with or without hepatocellular carcinoma, chronic renal failure, heart failure, or any malignancy other than epithelial ovarian cancer, 2) pregnancy, 3) previous history of malignancy or current evidence of any malignancy other than epithelial ovarian cancer, 4) recurred epithelial ovarian cancer or benign ovarian tumor, or 5) previous history of abdominal surgery.
PubMedID- 26166077 Magnetic resonance spectroscopy was used as a means of predicting the probability of developing hepatocellular carcinoma (hcc) in patients with liver cirrhosis secondary to chronic hepatitis b.this study included 20 healthy volunteers, 20 patients with liver cirrhosis secondary to chronic hepatitis b (cirrhosis group), and 20 patients with small hcc secondary to cirrhosis liver parenchyma (hcc group).
PubMedID- 25138286 Purpose: the aim of this retrospective cohort study was to clarify the effect of a branched-chain amino acids (bcaa) on the liver function and the prognosis of child-pugh class (c-p) a and b liver cirrhosis (lc) patients with advanced hepatocellular carcinoma (ahcc) undergoing hepatic arterial infusion chemotherapy (haic).
PubMedID- 22346290 A 44-year-old woman presented 3 years ago because of chronic hepatitis b-related liver cirrhosis with advanced multifocal hepatocellular carcinoma (hcc).
PubMedID- 23316254 Demonstrate that sorafenib-induced th1 dominance can prevent the escape of tumor cells from the host immune system in liver cirrhosis (lc) patients with advanced hepatocellular carcinoma (ahcc).
PubMedID- 25574115 Twaij and colleagues have carried out a meta-analysis of cohort studies to review the currently available literature comparing laparoscopic to open resection of hepatocellular carcinoma in patients with known liver cirrhosis.
PubMedID- 22606287 Ald-associated disorders include fatty liver, inflammation, and hepatocellular carcinoma in patients with liver cirrhosis [41].
PubMedID- 22882828 Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis.
PubMedID- 24229043 A 69-year-old woman, who underwent cadaveric liver transplantation for non-b, non-c liver cirrhosis with hepatocellular carcinoma in april 2009, was admitted to our hospital because of graft dysfunction.
PubMedID- 23320019 In two studies performed on mrcc patients or liver cirrhosis patients with advanced hepatocellular carcinoma treated with sorafenib, no impact on th1 response has been observed [42, 44].
PubMedID- 21318009 Moreover, chronic alcohol consumption is an established risk factor for the development of hepatocellular carcinoma in patients with liver cirrhosis [110].
PubMedID- 22483505 The patient was a 62-year-old man, who suffered decompensated liver cirrhosis with hepatocellular carcinoma.
PubMedID- 21388559 In 40-60% of hcv-infected individuals, persistent infection is mainly associated with liver cirrhosis and steatosis, leading to hepatocellular carcinoma (hcc) [2,3].
PubMedID- 23372775 In china, approximately 40 million people are infected with hcv [5], and it is estimated that 50% to 85% of all individuals infected with hcv develop chronic hepatitis; of these patients, 20% to 30% progress to liver cirrhosis that may lead to hepatocellular carcinoma (hcc).
PubMedID- 25963079 Using seldi-tof ms, serum protein/peptide profiles on the cm10 proteinchip arrays were obtained from a training group including 26 hbv-associated hepatocellular carcinoma patients with liver cirrhosis (lc), 30 hbv-associated lc patients, 85 patients at different stages of liver fibrosis, and 30 asymptomatic hbv carriers.
PubMedID- 22776279 Their perioperative course was favorable and comparable to that of other hepatocellular carcinoma patients with mild-moderate liver cirrhosis.
PubMedID- 20345561 Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis.
PubMedID- 23958083 Background & aims: liver transplantation (lt) is a promising treatment for patients with liver cirrhosis associated with hepatocellular carcinoma (hcc).
PubMedID- 23392977 Impact of laparoscopic liver resection for hepatocellular carcinoma with f4-liver cirrhosis.
PubMedID- 22504244 We describe a well-differentiated hepatocellular carcinoma (hcc) with alcohol-related liver cirrhosis in a 69-year-old man.
PubMedID- 20372847 Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis.
PubMedID- 25785114 Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with hbv-associated liver cirrhosis in china.
PubMedID- 25891119 The present study examined the prognostic ability of our proposed performance status combined japan integrated staging (ps-jis) system in hepatocellular carcinoma (hcc) patients with liver cirrhosis (lc) comparing with other four prognostic systems including original jis system, the barcelona clinic liver cancer classification system, tnm classification system and the cancer of the liver italian program (clip) scoring system.
PubMedID- 20736226 Left atrial metastasis from hepatocellular carcinoma with liver cirrhosis.
PubMedID- 20304209 The best treatment for hepatocellular carcinoma (hcc) associated with liver cirrhosis is liver transplantation and the best results are obtained when the tumors fulfill the milan criteria.
PubMedID- 26331402 Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with child-pugh c liver cirrhosis.
PubMedID- 26444667 Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma.
PubMedID- 23126044 hepatocellular carcinoma mostly develops in patients with liver cirrhosis due to chronic hepatitis c virus (hcv) infection.
PubMedID- 19345541 Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation.
PubMedID- 19955816 Impact of serial hepatitis b virus dna on hepatocellular carcinoma development in patients with liver cirrhosis.
PubMedID- 25841913 Management of liver cirrhosis in patients with hepatocellular carcinoma.
PubMedID- 23690654 These findings precluded the patient from resectional surgery on the basis of bilateral hepatocellular carcinoma with extensive liver cirrhosis.
PubMedID- 22028976 In hepatocellular carcinoma, all patients with liver cirrhosis or chronic hepatitis b virus infection are at risk.
PubMedID- 21896165 In 40-60% of hcv-infected individuals, chronic infection is mainly associated with liver cirrhosis and steatosis, leading to hepatocellular carcinoma (hcc) [3,4].
PubMedID- 21695929 Its efficacy was shown in the sharp study that enabled licensing of sorafenib for the therapy of inoperable, metastasizing hepatocellular carcinoma, including patients with liver cirrhosis, functional class child-pugh a or b, in more than 60 countries worldwide, including the czech republic.
PubMedID- 23708326 Branched-chain amino acids (bcaas) reportedly inhibit the incidence of hepatocellular carcinoma (hcc) in patients with liver cirrhosis and obesity that is frequently associated with insulin resistance (ir).
PubMedID- 19701751 Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis.

Page: 1 2